![ACIP Evidence to Recommendations (EtR) for Use of Novavax COVID-19 Vaccine Booster Dose for adults ages 18 years and older under an Emergency Use Authorization | CDC ACIP Evidence to Recommendations (EtR) for Use of Novavax COVID-19 Vaccine Booster Dose for adults ages 18 years and older under an Emergency Use Authorization | CDC](https://www.cdc.gov/vaccines/acip/recs/grade/images/novavax-04-adult-schedule.png?_=39257)
ACIP Evidence to Recommendations (EtR) for Use of Novavax COVID-19 Vaccine Booster Dose for adults ages 18 years and older under an Emergency Use Authorization | CDC
![Novavax vaccine for adolescents aged 12–17 years | Australian Government Department of Health and Aged Care Novavax vaccine for adolescents aged 12–17 years | Australian Government Department of Health and Aged Care](https://www.health.gov.au/sites/default/files/images/news/2022/08/novavax-vaccine-for-adolescents-aged-12-17-years_0.png)
Novavax vaccine for adolescents aged 12–17 years | Australian Government Department of Health and Aged Care
![Notes from the Field: Safety Monitoring of Novavax COVID-19 Vaccine Among Persons Aged ≥12 Years — United States, July 13, 2022–March 13, 2023 | MMWR Notes from the Field: Safety Monitoring of Novavax COVID-19 Vaccine Among Persons Aged ≥12 Years — United States, July 13, 2022–March 13, 2023 | MMWR](https://www.cdc.gov/mmwr/volumes/72/wr/social-media/mm7231a4_NovavaxSafety_IMAGE_04Aug2023_1200x675.jpg?_=86488)
Notes from the Field: Safety Monitoring of Novavax COVID-19 Vaccine Among Persons Aged ≥12 Years — United States, July 13, 2022–March 13, 2023 | MMWR
![Novavax Expects Its Updated COVID-19 Vaccine Candidate to Work on Circulating Variants | Health News | U.S. News Novavax Expects Its Updated COVID-19 Vaccine Candidate to Work on Circulating Variants | Health News | U.S. News](https://www.usnews.com/object/image/00000188-91df-d70a-ab9b-b5dfc3d80000/ap22159814230246.jpg?update-time=1686075120969&size=responsive640)
Novavax Expects Its Updated COVID-19 Vaccine Candidate to Work on Circulating Variants | Health News | U.S. News
![ACIP Evidence to Recommendations (EtR) for Use of Novavax COVID-19 Vaccine Booster Dose for adults ages 18 years and older under an Emergency Use Authorization | CDC ACIP Evidence to Recommendations (EtR) for Use of Novavax COVID-19 Vaccine Booster Dose for adults ages 18 years and older under an Emergency Use Authorization | CDC](https://www.cdc.gov/vaccines/acip/recs/grade/images/novavax-01-adult-schedule.png?_=39259)